Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 7/20 | 0.42 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 5/20 | 0.42 |
| ▸ | CA12 | O43570 | 4/20 | 0.42 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18179739 | 0.93 | USP2 (0.46) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL18179734 | 0.92 | USP2 (0.38) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL18179732 | 0.87 | USP2 (0.56) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL18179736 | 0.85 | ESR1 (0.38) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL18179747 | 0.81 | USP2 (0.54) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL18179738 | 0.80 | USP2 (0.48) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL15143727 | 0.75 | USP2 (0.40) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL18179769 | 0.74 | USP2 (0.40) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL15143726 | 0.73 | USP2 (0.53) | USP2L3MBTL1ESR1CA9CA1 | |
| SCHEMBL13763752 | 0.71 | P2RY6 (0.53) | USP2L3MBTL1ESR1CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160312033-A1 | DIARYLETHER-BASED FLUOROGENIC PROBES FOR DETECTION OF HYPOCHLOROUS ACID OR HYDROXYL RADICAL | VERSITECH LIMITED (HK) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160312033-A1 | DIARYLETHER-BASED FLUOROGENIC PROBES FOR DETECTION OF HYPOCHLOROUS ACID OR HYDROXYL RADICAL | HAGH, HADH, FECH | USP2 1219/4885L3MBTL1 2301/4885ESR1 3340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.